TAM
Trillium Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3M | Sell |
74,825
-5,439
| -7% | -$2.21M | 0.82% | 36 |
|
|
2025
Q1 | $39.9M | Sell |
80,264
-3,065
| -4% | -$1.53M | 1.15% | 25 |
|
|
2024
Q4 | $43.4M | Sell |
83,329
-4,366
| -5% | -$2.27M | 1.12% | 18 |
|
|
2024
Q3 | $54.2M | Sell |
87,695
-1,761
| -2% | -$1.09M | 1.33% | 13 |
|
|
2024
Q2 | $49.5M | Sell |
89,456
-3,241
| -3% | -$1.79M | 1.25% | 16 |
|
|
2024
Q1 | $53.9M | Sell |
92,697
-253
| -0.3% | -$147K | 1.37% | 14 |
|
|
2023
Q4 | $49.3M | Buy |
92,950
+1,135
| +1% | +$602K | 1.34% | 15 |
|
|
2023
Q3 | $46.5M | Buy |
91,815
+1,112
| +1% | +$563K | 1.4% | 12 |
|
|
2023
Q2 | $47.3M | Buy |
90,703
+9,178
| +11% | +$4.79M | 1.33% | 15 |
|
|
2023
Q1 | $45.3M | Buy |
81,525
+1,621
| +2% | +$901K | 1.33% | 20 |
|
|
2022
Q4 | $44M | Sell |
79,904
-45
| -0.1% | -$24.8K | 1.35% | 17 |
|
|
2022
Q3 | $40.5M | Buy |
79,949
+2,386
| +3% | +$1.21M | 1.33% | 16 |
|
|
2022
Q2 | $42.4M | Buy |
77,563
+8,993
| +13% | +$4.91M | 1.3% | 17 |
|
|
2022
Q1 | $40.5M | Buy |
68,570
+31,359
| +84% | +$18.5M | 1.08% | 25 |
|
|
2021
Q4 | $24.8M | Buy |
37,211
+1,231
| +3% | +$821K | 0.58% | 65 |
|
|
2021
Q3 | $20.6M | Buy |
35,980
+16,887
| +88% | +$9.65M | 0.54% | 69 |
|
|
2021
Q2 | $9.59M | Buy |
19,093
+2,298
| +14% | +$1.15M | 0.26% | 96 |
|
|
2021
Q1 | $7.66M | Buy |
16,795
+4,932
| +42% | +$2.25M | 0.24% | 102 |
|
|
2020
Q4 | $5.53M | Buy |
+11,863
| New | +$5.53M | 0.2% | 106 |
|
|
2019
Q4 | – | Sell |
-1,262
| Closed | -$367K | – | 273 |
|
|
2019
Q3 | $367K | Buy |
+1,262
| New | +$367K | 0.02% | 221 |
|
|
2013
Q4 | – | Sell |
-4,269
| Closed | -$393K | – | 188 |
|
|
2013
Q3 | $393K | Buy |
+4,269
| New | +$393K | 0.04% | 161 |
|